Menu
Back to Journals » Clinical Ophthalmology » Volume 6
Exogenous group G Streptococcus endophthalmitis following intravitreal ranibizumab injection
Authors Kugu S, Sevim MS , Kaymak NZ, Erdogan G, Kandemir, Dogan KO
Received 12 March 2012
Accepted for publication 19 May 2012
Published 28 August 2012 Volume 2012:6 Pages 1399—1402
DOI https://doi.org/10.2147/OPTH.S31721
Review by Single anonymous peer review
Peer reviewer comments 3
Suleyman Kugu,1 Mehmet Sahin Sevim,2 Nilufer Zorlutuna Kaymak,1 Gurkan Erdogan,3 Baran Kandemir,1 Omer Kamil Dogan4
1Lutfi Kirdar Kartal Training and Research Hospital, Eye Clinic, Istanbul, 2Haydarpasa Numune Training and Research Hospital, Eye Clinic, Istanbul, 3Umraniye Training and Research Hospital, Eye Clinic, Istanbul, 4World Eye Hospital, Eye Clinic, Istanbul, Turkey
Abstract: We report a case of group G Streptococcus endophthalmitis following an intravitreal ranibizumab injection for a choroidal neovascular membrane. Pars plana vitrectomy was applied for endophthalmitis and group G Streptococcus cultures were isolated in the vitreous samples taken from the patient. Twenty-four hours following pars plana vitrectomy the patient underwent myocardial infarction and cardiac arrest. To our knowledge this is the first reported case of group G Streptococcus endophthalmitis following an intravitreal injection.
Keywords: group G Streptococcus, endophthalmitis, intravitreal injection
© 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.